Hints : [1] Click the icon table to view the Meeting detail page.
Click here to modify the Visible Columns.
Ann. Date
Date
Time
Type
Venue
View
05-Oct-2023
06-Nov-2023
10:00
General Meeting
Dewan Utama 1, Hotel Seri Malaysia, Lot 979 & 980
Pantai Bagan Lalang
43950 Sungai Pelek, Sepang
Selangor Darul Ehsan
17-Oct-2022
16-Nov-2022
10:00
General Meeting
Dewan Utama 1, Hotel Seri Malaysia, Lot 979 & 980,,Pantai Bagan Lalang,43950 Sungai Pelek, Sepang,Selangor Darul Ehsan,MY
15-Oct-2021
16-Nov-2021
10:00
General
Virtually through live streaming via a remote participation and voting
facilities at the Broadcast Venue at
Conference Room, Nova Laboratories Sdn. Bhd., Lot 708, Nova Avenue,
43950 Sungai Pelek, Selangor Darul Ehsan
08-Oct-2021
16-Nov-2021
11:30
Extraordinary
Virtually through live streaming via a remote participation and voting
facilities at the Broadcast Venue at
Conference Room, Nova Laboratories Sdn. Bhd., Lot 708, Nova Avenue,
43950 Sungai Pelek, Selangor Darul Ehsan
09-Nov-2020
16-Nov-2020
10:00
General
Conference Room, Nova Laboratories Sdn. Bhd.,
Lot 708, Nova Avenue 4th Mile,
43950 Sungai Pelek, Selangor Darul Ehsan
25-Oct-2019
27-Nov-2019
10:00
AGM
DEWAN BAGAN, HOTEL SERI MALAYSIA BAGAN LALANG,
LOT 979 & 980, PANTAI BAGAN LALANG,
43950 SUNGAI PELEK, SELANGOR
29-Oct-2018
27-Nov-2018
10:30
AGM
Mentari Hall 5
Movenpick Hotel & Convention Centre KLIA
Kompleks TH Sepang
Jalan Masjid KLIA
64000 Sepang
Selangor Darul Ehsan
shortinvestor77On behalf of the Board, Kenanga IB wishes to inform that Bursa Securities had, vide its letter dated 19 January 2021, approved the Transfer under the “Health Care” sector.
The Transfer will take effect immediately two (2) market days upon the announcement to Bursa Securities on the transfer date via Bursa Link.
This announcement is dated 20 January 2021. https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3122541
HantuRaya2020Mau jual ka simpan? Atau tunggu dividen?
09/11/2021 11:14 AM
catalanThe Board of Directors of Nova Wellness Group Berhad wishes to announce the positive results from the recently completed Hepar-P clinical trial to assess its efficacy and safety in patients with Non-Alcoholic Fatty Liver Disease (NAFLD).